trending Market Intelligence /marketintelligence/en/news-insights/trending/Bt1Qf-dMQLVyTWLV0J05Cg2 content esgSubNav
In This List

GlycoMimetics appoints director

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


GlycoMimetics appoints director

GlycoMimetics Inc. appointed Patricia Andrews to its board of directors.

Andrews is CEO and director of privately held Boston Biomedical Inc.